Roger Song
Stock Analyst at Jefferies
Total Price Targets
31
Stocks Covered
20
Sectors
Healthcare
Most Recent
Mar 18, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Roger Song
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics, Inc. | $16.00 | $4.16 | +285.1% | 3 | Mar 18, 2026 |
| PTGX | Protagonist Therapeutics, Inc. | $121.00 | $98.16 | +23.3% | 1 | Mar 18, 2026 |
| VKTX | Viking Therapeutics, Inc. | $101.00 | $29.80 | +238.9% | 2 | Mar 12, 2026 |
| MANE | Veradermics, Incorporated | $75.00 | $101.40 | -26.0% | 1 | Mar 2, 2026 |
| BIOA | BioAge Labs, Inc. | $62.00 | $16.82 | +268.7% | 3 | Feb 18, 2026 |
| KRYS | Krystal Biotech, Inc. | $371.00 | $265.25 | +39.9% | 1 | Feb 17, 2026 |
| CRVS | Corvus Pharmaceuticals, Inc. | $42.00 | $15.49 | +171.2% | 2 | Jan 22, 2026 |
| ZBIO | Zenas BioPharma, Inc. | $48.00 | $19.50 | +146.2% | 3 | Jan 6, 2026 |
| NKTR | Nektar Therapeutics | $121.00 | $86.71 | +39.5% | 2 | Nov 24, 2025 |
| GYRE | Gyre Therapeutics, Inc. | $16.00 | $7.83 | +104.3% | 1 | Oct 10, 2025 |
| UTHR | United Therapeutics Corporation | $564.00 | $571.24 | -1.3% | 1 | Sep 2, 2025 |
| ATYR | aTyr Pharma, Inc. | $17.00 | $0.83 | +1944.5% | 1 | Aug 22, 2025 |
| REPL | Replimune Group, Inc. | $19.00 | $2.46 | +673.9% | 1 | Dec 3, 2024 |
| ACRS | Aclaris Therapeutics, Inc. | $7.00 | $4.38 | +59.6% | 1 | Nov 19, 2024 |
| PCVX | Vaxcyte, Inc. | $146.00 | $57.52 | +153.8% | 2 | Nov 6, 2024 |
| IRON | Disc Medicine, Inc. | $89.00 | $67.31 | +32.2% | 1 | Oct 23, 2024 |
| NVAX | Novavax, Inc. | $25.00 | $8.04 | +211.1% | 2 | Oct 16, 2024 |
| NRIX | Nurix Therapeutics, Inc. | $41.00 | $16.83 | +143.6% | 1 | Oct 11, 2024 |
| KNSA | Kiniksa Pharmaceuticals, Ltd. | $40.00 | $54.56 | -26.7% | 1 | Sep 13, 2024 |
| NUVL | Nuvalent, Inc. | $97.00 | $99.45 | -2.5% | 1 | Apr 17, 2024 |
Recent Activity
- Mar 18, 2026— Set$121.00price target onPTGX(Protagonist Therapeutics, Inc.)
- Mar 18, 2026— Set$16.00price target onCTMX(CytomX Therapeutics, Inc.)
- Mar 12, 2026— Set$101.00price target onVKTX(Viking Therapeutics, Inc.)
- Mar 2, 2026— Set$75.00price target onMANE(Veradermics, Incorporated)
- Feb 18, 2026— Set$62.00price target onBIOA(BioAge Labs, Inc.)
- Feb 17, 2026— Set$371.00price target onKRYS(Krystal Biotech, Inc.)
- Jan 22, 2026— Set$42.00price target onCRVS(Corvus Pharmaceuticals, Inc.)
- Jan 6, 2026— Set$48.00price target onZBIO(Zenas BioPharma, Inc.)
- Nov 24, 2025— Set$121.00price target onNKTR(Nektar Therapeutics)
- Oct 27, 2025— Set$52.00price target onZBIO(Zenas BioPharma, Inc.)
- Oct 10, 2025— Set$16.00price target onGYRE(Gyre Therapeutics, Inc.)
- Sep 18, 2025— Set$99.00price target onNKTR(Nektar Therapeutics)
- Sep 2, 2025— Set$564.00price target onUTHR(United Therapeutics Corporation)
- Aug 22, 2025— Set$17.00price target onATYR(aTyr Pharma, Inc.)
- Dec 9, 2024— Set$7.00price target onBIOA(BioAge Labs, Inc.)
- Dec 3, 2024— Set$19.00price target onREPL(Replimune Group, Inc.)
- Nov 19, 2024— Set$7.00price target onACRS(Aclaris Therapeutics, Inc.)
- Nov 13, 2024— Set$13.00price target onCRVS(Corvus Pharmaceuticals, Inc.)
- Nov 6, 2024— Set$146.00price target onPCVX(Vaxcyte, Inc.)
- Nov 4, 2024— Set$110.00price target onVKTX(Viking Therapeutics, Inc.)
Frequently Asked Questions
Who is Roger Song?
Roger Song is a stock analyst at Jefferies covering 20 stocks primarily in Healthcare. They have issued 31 price targets since Mar 12, 2024.
What stocks does Roger Song cover?
Roger Song currently covers 20 stocks, including CTMX, BIOA, ZBIO, VKTX, CRVS.
What is Roger Song's latest price target?
Roger Song's most recent price target was $121.00 on PTGX (Protagonist Therapeutics, Inc.), set on Mar 18, 2026.
What is Roger Song's highest price target?
Roger Song's highest issued price target is $564.00 on UTHR, set on Sep 2, 2025.
More Analysts at Jefferies
Coverage based on publicly published price targets. Not investment advice.